Overview
Dysthymia, also known as persistent depressive disorder, is characterized by a chronic form of depression with less severe but longer-lasting symptoms compared to major depressive disorder 2.Diagnosis
Persistent depressed mood most of the day, for more days than not, for at least two years 2.
Presence of at least two additional depressive symptoms (e.g., diminished pleasure, fatigue, low self-esteem) 2.
Symptoms cause significant impairment in social, occupational, or other important areas of functioning 2.
Exclusion of other psychiatric disorders that might explain the presentation 2.Management
First-line treatments:
- Pharmacotherapy: Selective serotonin reuptake inhibitors (SSRIs), with fluoxetine specifically highlighted 2.
- Psychotherapy: Cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT) are recommended adjunctively 2.
Adjunctive treatments: Not specified in the provided abstracts 2.Special Populations
Pregnancy: No specific recommendations provided in the abstracts 2.
Pediatrics: No specific recommendations provided in the abstracts 2.
Elderly: No specific recommendations provided in the abstracts 2.
Comorbidities: Management considerations for comorbidities not detailed in the abstracts 2.Key Recommendations
Use pharmacotherapy, particularly SSRIs like fluoxetine, as a first-line treatment for dysthymia 2 (Evidence: Strong).
Incorporate psychotherapy, such as CBT or IPT, as an adjunctive treatment alongside pharmacotherapy 2 (Evidence: Moderate).
Individualize treatment plans considering patient-specific factors, though specific guidance for special populations is lacking 2 (Evidence: Expert opinion).References
1 Silva de Lima M, Moncrieff J, Soares BG. WITHDRAWN: Drugs versus placebo for dysthymia. The Cochrane database of systematic reviews 2015. link
2 Dunner DL. Treatment of dysthymic disorder. Depression and anxiety 1998. link